We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Biodegradación de plásticos farmacéuticos por bacterias nativas: evaluación experimental de la eficiencia y el potencial ambiental
Summary
Researchers evaluated the biodegradation potential of native bacterial strains -- Pseudomonas aeruginosa, Ideonella sakaiensis, and Bacillus subtilis -- isolated from landfill soil and wastewater sludge, against pharmaceutical plastic packaging materials including multilayer blister packs. The study found that these strains showed selective degradation capacity for polyethylene (PE) and other pharmaceutical-grade plastics, demonstrating potential for bioremediation of persistent plastic waste.
The extensive use of pharmaceutical plastics, such as multilayer blister packs and medical packaging, has contributed to persistent plastic pollution due to improper disposal and limited recycling options. This study investigated the biodegradation potential of native bacterial strains isolated from local landfill soil and wastewater sludge. Pseudomonas aeruginosa, Ideonella sakaiensis, and Bacillus subtilis were identified as key strains with selective degradation capacities for polyethylene (PE), PET, and polypropylene (PP), respectively. When combined in a bacterial consortium, these strains showed significantly higher degradation rates compared to individual cultures. Experimental analysis included weight loss measurements, enzyme activity assays, scanning electron microscopy to confirm surface erosion, and CO₂ evolution tests under semi-natural soil microcosm conditions. The results demonstrate that native bacterial consortia can break down pharmaceutical plastics efficiently, producing measurable mineralization and structural damage. This finding suggests that local bacterial communities could be used as a viable biotechnological alternative to supplement traditional plastic waste management strategies, particularly for pharmaceutical packaging. Further research should focus on scaling up this approach through long-term field tests and pilot bioreactor applications to validate its effectiveness under real conditions.